TY  - JOUR
AU  - Macias-Sanchez, Maria Del Mar
AU  - Morata-Tarifa, Cynthia
AU  - Cuende, Natividad
AU  - Cardesa-Gil, Ana
AU  - Cuesta-Casas, Maria Angeles
AU  - Pascual-Cascon, Maria Jesus
AU  - Pascual, Antonia
AU  - Martin-Calvo, Carmen
AU  - Jurado, Manuel
AU  - Perez-Simon, Jose Antonio
AU  - Espigado, Ildefonso
AU  - Garzon-Lopez, Sebastian
AU  - Carmona-Sanchez, Gloria
AU  - Mata-Alcazar-Caballero, Rosario
AU  - Sanchez-Pernaute, Rosario
PY  - 2022
DO  - 10.1093/stcltm/szac003
UR  - http://hdl.handle.net/10668/19839
T2  - Stem cells translational medicine
AB  - Graft versus host disease (GVHD) is a severe complication after allogenic hematopoietic cell transplantation (HSCT). Several clinical trials have reported the use of mesenchymal stromal cells (MSCs) for the treatment of GVHD. In March 2008, the...
LA  - en
PB  - Oxford University Press
KW  - Allogenic hematopoietic stem cell transplantation
KW  - Cell therapy
KW  - Graft versus host disease
KW  - Mesenchymal stromal cells
KW  - Área de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
KW  - Red Andaluza de Diseño y Traslación de Terapias Avanzadas
KW  - Acute Disease
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Child
KW  - Compassionate Use Trials
KW  - Female
KW  - Graft vs Host Disease
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Male
KW  - Mesenchymal Stem Cell Transplantation
KW  - Mesenchymal Stem Cells
KW  - Middle Aged
KW  - Steroids
KW  - Young Adult
TI  - Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience.
TY  - research article
VL  - 11
ER  -